Euroscreen
Pharmaceutical ManufacturingGosselies, Belgium11-50 Employees
Euroscreen S.A. is a Belgium-based, private, Drug Discovery and Development company providing first-in-class small molecule drug candidates for unmet medical needs. Euroscreen has a drug discovery track-record with multiple innovative and proprietary small-molecules. Euroscreen has advanced its orally-available and highly specific lead program ESN364 into clinical development for the treatment of Women’s Health Disorders. In addition, Euroscreen advances other small molecules (preclinical stage) targeting G-Protein Coupled Receptors of interest in multiple therapeutic areas such as neurodegenerative diseases and inflammation. Euroscreen is backed by leading investors, including Vesalius Biocapital, SRIW, and BNP Paribas Fortis Private Equity. Further information about Euroscreen can be found online at www.euroscreen.com
1-888-653-2347 
support@leadiq.com 
